These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 15257427)

  • 1. Identification of the regulatory proteins in human pancreatic cancers treated with Trichostatin A by 2D-PAGE maps and multivariate statistical analysis.
    Marengo E; Robotti E; Cecconi D; Hamdan M; Scarpa A; Righetti PG
    Anal Bioanal Chem; 2004 Aug; 379(7-8):992-1003. PubMed ID: 15257427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic profiling of pancreatic ductal carcinoma cell lines treated with trichostatin-A.
    Cecconi D; Scarpa A; Donadelli M; Palmieri M; Hamdan M; Astner H; Righetti PG
    Electrophoresis; 2003 Jun; 24(11):1871-8. PubMed ID: 12783462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Legendre moments for the fast comparison of two-dimensional polyacrylamide gel electrophoresis maps images.
    Marengo E; Bobba M; Liparota MC; Robotti E; Righetti PG
    J Chromatogr A; 2005 Nov; 1096(1-2):86-91. PubMed ID: 16301071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of proteomic changes associated with healthy and tumoral murine samples in neuroblastoma by principal component analysis and classification methods.
    Marengo E; Robotti E; Righetti PG; Campostrini N; Pascali J; Ponzoni M; Hamdan M; Astner H
    Clin Chim Acta; 2004 Jul; 345(1-2):55-67. PubMed ID: 15193978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the variables characterized by significant discriminating power in the application of SIMCA classification method to proteomic studies.
    Marengo E; Robotti E; Bobba M; Righetti PG
    J Proteome Res; 2008 Jul; 7(7):2789-96. PubMed ID: 18543959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Differential proteomic analysis of human colorectal carcinoma cell lines SW620 and SW480 with different metastatic potentials].
    Qu LJ; Ding YQ; Liang L
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Oct; 25(10):1211-5, 1220. PubMed ID: 16234091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
    Yu KH; Rustgi AK; Blair IA
    J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of differentially expressed proteins in pancreatic cancer using a global proteomic approach.
    Rosty C; Goggins M
    Methods Mol Med; 2005; 103():189-97. PubMed ID: 15542907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Proteomic analysis of human ovarian cancer cell lines and their platinum-resistant clones].
    Yan XD; Pan LY
    Zhonghua Fu Chan Ke Za Zhi; 2006 Sep; 41(9):584-7. PubMed ID: 17181965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic analysis to identify biomarker proteins in pancreatic ductal adenocarcinoma.
    Chung JC; Oh MJ; Choi SH; Bae CD
    ANZ J Surg; 2008 Apr; 78(4):245-51. PubMed ID: 18366394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic analysis of differentially expressed proteins between metastatic and non-metastatic human colorectal carcinoma cell lines.
    Ying-Tao Z; Yi-Ping G; Lu-Sheng S; Yi-Li W
    Eur J Gastroenterol Hepatol; 2005 Jul; 17(7):725-32. PubMed ID: 15947549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic analysis of pancreatic endocrine tumor cell lines treated with the histone deacetylase inhibitor trichostatin A.
    Cecconi D; Donadelli M; Rinalducci S; Zolla L; Scupoli MT; Scarpa A; Palmieri M; Righetti PG
    Proteomics; 2007 May; 7(10):1644-53. PubMed ID: 17443844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic differential display analysis for TS-1-resistant and -sensitive pancreatic cancer cells using two-dimensional gel electrophoresis and mass spectrometry.
    Yoshida K; Kuramitsu Y; Murakami K; Ryozawa S; Taba K; Kaino S; Zhang X; Sakaida I; Nakamura K
    Anticancer Res; 2011 Jun; 31(6):2103-8. PubMed ID: 21737628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of three-way principal component analysis to the evaluation of two-dimensional maps in proteomics.
    Marengo E; Leardi R; Robotti E; Righetti PG; Antonucci F; Cecconi D
    J Proteome Res; 2003; 2(4):351-60. PubMed ID: 12938925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteins isolated with TRIzol are compatible with two-dimensional electrophoresis and mass spectrometry analyses.
    Young C; Truman P
    Anal Biochem; 2012 Feb; 421(1):330-2. PubMed ID: 22107888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of fluorescence difference gel electrophoresis saturation labelling for the analysis of microdissected precursor lesions of pancreatic ductal adenocarcinoma.
    Sitek B; Lüttges J; Marcus K; Klöppel G; Schmiegel W; Meyer HE; Hahn SA; Stühler K
    Proteomics; 2005 Jul; 5(10):2665-79. PubMed ID: 15924292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic analysis of pancreatic ductal carcinoma cells after combined treatment with gemcitabine and trichostatin A.
    Cecconi D; Donadelli M; Scarpa A; Milli A; Palmieri M; Hamdan M; Areces LB; Rappsilber J; Righetti PG
    J Proteome Res; 2005; 4(6):1909-16. PubMed ID: 16335935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gel-based proteomics analysis of the heterogeneity of 20S proteasomes from four human pancreatic cancer cell lines.
    Wang X; Zhao Z; Luo Y; Chen G; Li Z
    Proteomics Clin Appl; 2011 Oct; 5(9-10):484-92. PubMed ID: 21751412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic analysis of the basic proteins in 5-fluorouracil resistance of human colon cancer cell line using the radical-free and highly reducing method of two-dimensional polyacrylamide gel electrophoresis.
    Tanaka S; Sakai A; Kimura K; Yoshida H; Fushitani H; Ogata A; Miyamoto A; Fukushima M; Wada A; Tanigawa N
    Int J Oncol; 2008 Aug; 33(2):361-70. PubMed ID: 18636157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2D-DIGE analysis of ovarian cancer cell responses to cytotoxic gold compounds.
    Guidi F; Puglia M; Gabbiani C; Landini I; Gamberi T; Fregona D; Cinellu MA; Nobili S; Mini E; Bini L; Modesti PA; Modesti A; Messori L
    Mol Biosyst; 2012 Apr; 8(4):985-93. PubMed ID: 22134777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.